Signaling Pathway
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25079 | Sevabertinib ( BAY-2927088 ) | 2521285-05-0 | ≧98.0% |  |
| Sevabertinib ( BAY-2927088 ) is a oral, non-covalent, tyrosine kinase receptor inhibi | ||||
| 20633 | Tersolisib ( STX-478 ) | 2883540-92-7 | ≧98.0% |  |
| Tersolisib ( STX-478 )is a second generation, mutant-selective, oral PI3Ka small mole | ||||
| 24084 | Iclepertin (BI-425809) | 1421936-85-7 | ≧98.0% | _1421936-85-7.png) |
| Iclepertin (BI-425809) is an oral, small-molecule inhibitor of GlyT-1for the treatmen | ||||
| 20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% |  |
| Zilurgisertib (earlier known as INCB 00928) is an activin receptor-like kinase-2 (ALK | ||||
| 24107 | LXH-3-71 | 2251753-65-6 | ≧97.0% |  |
| LXH-3-71 isnovel "molecular glue"that induces the interaction between PHGDH | ||||
| 24067 | PBT434 Hydrobromide | 1232841-78-9 | ≧98.0% |  |
| PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein | ||||
| 20656 | IK-930 | 2563892-44-2 | ≧98.0% |  |
| IK-930 is a novel, selective, small molecule inhibitor of TEAD that prevents palmitat | ||||
| 21238 | Seralutinib | 1619931-27-9 | 98% Min. |  |
| Seralutinib, also known as PK-10571 and GB002, is a Novel Inhaled Pdgfr Kinase Inhibi | ||||
| 24001 | Bomedemstat | 1990504-34-1 | ≧98.0% |  |
| Bomedemstat is anorally available, irreversible inhibitor of lysine-specific demethyl | ||||
| 24017 | AMG-193 | 2790567-82-5 | 98.62%; EE 98.28% |  |
| AMG-193 is an oral, small-molecule, methylthioadenosine-cooperative inhibitor of the | ||||
| 25080 | LOXO-435 | 2833703-74-3 | ≧98.0% |  |
| LOXO-435 is a selective small molecule inhibitor of FGFR3. It is active against both | ||||
| 24003 | NVL-655 ( ALK-IN-27 ) | 2739866-40-9 | ≧98.0% | .png) |
| NVL-655 is a novel, brain-penetrant, ALK-selective inhibitor that was designed to add | ||||